Business
Guerbet : Adjustment of 2025 full-year financial targets
Adjustment of 2025 full-year financial targets Villepinte, 15 September 2025, 5.45 p.m.: Guerbet (FR0000032526 GBT), a global specialist in contrast agents and solutions for medical imaging, is announcing a downward revision to its financial targets for full-year 2025. Business activity in France continues to be impacted by supply reforms. In the United States, an unfavourable shift in the customer mix, with distributors representing a higher proportion of sales and ongoing pricing pressures has
About this update from Guerbet Sa
[{"type":"image","alt":"GUERBET","displaySize":"","headline":null,"caption":"GUERBET","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":105,"url":"https://media.zenfs.com/en/globenewswire.com/3975ab9f5076034731af8ca99ee4b169"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/XW0Ga4G5pYagH_4N.1hQ2Q--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTE0NztjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/3975ab9f5076034731af8ca99ee4b169","width":300,"height":105}},"lazy":false},{"type":"text","content":"Adjustment of 2025 full-year financial targets","length":46,"tagName":"p"},{"type":"text","content":" ","length":180,"tagName":"p"},{"type":"text","content":"Villepinte, 15 September 2025, 5.45 p.m.: Guerbet (FR0000032526 GBT), a global specialist in contrast agents and solutions for medical imaging, is announcing a downward revision to its financial targets for full-year 2025.","length":222,"tagName":"p"},{"type":"text","content":"Business activity in France continues to be impacted by supply reforms. In the United States, an unfavourable shift in the customer mix, with distributors representing a higher proportion of sales and ongoing pricing pressures has added to these challenges. Further compounding the situation was a technical issue, now resolved, that occurred during the restart of operations at the Raleigh site following routine maintenance. These factors have collectively contributed to a contraction in growth and profitability for the Group in the current year.","length":550,"tagName":"p"},{"type":"text","content":"As a result, Guerbet’s management is revising its guidance for the full year 2025 as follows:","length":93,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Revenue is now expected to decline slightly by approximately 1% at constant exchange rates and on a like-for-like basis, compared to the previously anticipated growth of 3–5%.","length":175,"tagName":"p"}]},{"val":[{"type":"text","content":"Restated EBITDA margin is now forecast to be in the range of 12–13%, down from the earlier guidance of “above 15%.”","length":115,"tagName":"p"}]},{"val":[{"type":"text","content":"Free cash flow is expected to be slightly...